Phase 3 Data of Cytori Therapy for Condition that Can Lead to Raynaud’s to Be Presented at Meeting
News
Cytori Therapeutics will present data from its Phase 3 STAR clinical trial (NCT02396238) assessing the safety and effectiveness of adipose-derived regenerative cells (ADRCs) for the treatment of hand dysfunction due to scleroderma, ... Read more